Baseline characteristics of the 192 eligible cervical cancer patients
| Characteristics | Number (%) |
| Number of patients | 192 |
| Age (years)* | 48.0±9.2 |
| Stage (FIGO 2009) | |
| IB1 | 109 (56.8) |
| IB2 | 8 (4.2) |
| IIA1 | 72 (37.5) |
| IIA2 | 3 (1.6) |
| Diameter of tumor (cm) | |
| ≤2 | 28 (14.6) |
| >2 to ≤4 | 107 (55.7) |
| >4 | 57 (29.7) |
| Histology | |
| SCC | 162 (84.4) |
| AC | 16 (8.3) |
| ASC | 14 (7.3) |
| Tumor grade | |
| Grade 1~2 | 59 (30.7) |
| Grade 3 | 132 (68.8) |
| Unknown | 1 (0.5) |
| Depth of stromal invasion | |
| <1/2 | 43 (22.4) |
| ≥1/2 | 149 (77.6) |
| LVSI | |
| No | 116 (60.4) |
| Yes | 75 (39.1) |
| Unknown | 1 (0.5) |
| Parametrial involvement | |
| No | 182 (94.8) |
| Yes | 10 (5.2) |
| Surgical margins | |
| Negative | 173 (90.1) |
| Positive | 19 (9.9) |
| Surgical approach | |
| Laparotomy | 188 (97.9) |
| Laparoscopic | 4 (2.1) |
| Para-aortic LN dissection | |
| No | 152 (79.2) |
| Yes | 40 (20.8) |
| Vaginal involvement | |
| No | 173 (90.1) |
| Yes | 19 (9.9) |
| Number of LN removed* | 24.3±8.9 |
| Number of positive LN | |
| Mean* | 3.5±5.5 |
| 1 | 85 (44.3) |
| ≥2 | 107 (55.7) |
| Location of positive LN | |
| Only pelvic | 177 (92.2) |
| Pelvic+para-aortic | 15 (7.8) |
| Common iliac LN | |
| Negative | 161 (83.9) |
| Positive | 31 (16.1) |
| Adjuvant treatment | |
| RT | 25 (13.0) |
| CCRT | 40 (20.8) |
| SCRT | 127 (66.1) |
*Value is mean (±SD).
AC, adenocarcinoma; ASC, adenosquamous carcinoma; CCRT, concurrent chemoradiation; FIGO, International Federation of Gynecology and Obstetrics; LN, lymph node; LVSI, lymphovascular space invasion; RT, radiotherapy; SCC, squamous cell carcinoma; SCRT, sequential chemoradiation.